FDA Extends Shelf-Life of J&J COVID-19 Vaccine
From: Mitchel C. Rothholz, RPh, MBA, Chief of Governance & State Affiliates and Executive Director, APhA Foundation, American Pharmacists Association
The Food & Drug Administration authorized an extension of the shelf life for the Johnson & Johnson’s Janssen COVID-19 vaccine from 4.5 months to 6 months (an additional 45 days). The decision is based on data from ongoing stability assessment studies, which have demonstrated that the vaccine is stable at 6 months when refrigerated at temperatures of 36 – 46 degrees Fahrenheit (2 – 8 degrees Celsius).
https://vaxcheck.jnj
Vaccine providers should visit https://vaxcheck.jnj/ to confirm the latest expiration dates of vaccine, including those currently available for administration throughout the U.S. This extension applies to refrigerated vials of J&J/Janssen COVID-19 vaccine that have been held in accordance with the manufacturer’s storage conditions.
COVID-19 vaccines that are authorized under an EUA do not have fixed expiration dates, and their expiration dates can be extended as we get more stability data. Always be sure to check the manufacturer’s website to obtain the most up-to-date expiration dates for COVID-19 vaccines you have on hand.
